Global procurement services.
End-to-end sourcing of medical devices, IVDs, and pharmaceuticals from European supply chains. Built for organisations outside the EU that need access without building local infrastructure.
What we mean by global procurement.
Procurement is the operational layer that decides whether a cross-border medical supply chain works. Regulations, distribution agreements, language, currency, customs, cold chain — every layer adds risk and delay. Cervixel acts as a strategic European partner that handles those layers on the customer’s behalf.
Engagements run on three operational tracks. The first is CE-marked medical devices and IVDs aligned with MDR and IVDR. The second is pharmaceutical procurement through verified European distribution networks. The third is vendor auditing for clinical and technical reliability before any order is placed.
Every project closes with a Standard Comprehensive Report — a written document covering vendor assessment, price benchmarking, regulatory documentation for international customs and local health authorities, and logistics and cold-chain verification where applicable.
Who we source for.
Healthcare systems and hospital networks outside the EU
Public and private healthcare systems sourcing CE-marked devices and IVDs from European supply chains, with the documentation their own regulators expect.
Pharmaceutical distributors
Distributors needing verified European supply with full compliance documentation, vendor audits, and benchmarking before any commitment.
Research institutions and government bodies
Organisations procuring under regulated conditions where an audit trail and a documented vendor assessment are non-negotiable.
How a procurement engagement runs.
Scope is agreed in writing before any sourcing activity begins. Vendor shortlists are reviewed with the customer; audit and benchmarking work is documented as it happens, not summarised at the end. The engagement closes with the Standard Comprehensive Report — vendor assessment, regulatory documentation, logistics and cold-chain verification — handed over as the artifact the customer can carry forward to their own regulators, customs authorities, and internal review.
Other ways we partner.
CRISPR assay development
Design and optimisation of Cas-based detection assays for nucleic-acid targets in clinical and research settings.
Molecular diagnostics consulting
Strategic guidance on assay architecture, sample workflows, and translation from concept to clinical use.
Clinical validation support
Study design, partner sourcing, and analytical-to-clinical performance evaluation for diagnostic candidates.
Regulatory strategy
IVDR-aligned planning for CE marking pathways, technical-file structuring, and post-market surveillance.
Contract research
Targeted laboratory work for biotech and pharmaceutical partners — flexible scope, rigorous documentation.
Source it through Europe with us.
Tell us what you need to procure and where it has to land. We’ll write you a scope and a vendor shortlist before any order moves.